InvestorsHub Logo
icon url

sunstar

08/11/07 10:37 PM

#16247 RE: mmignot #16246

Mark, I don’t know any absolute numbers, and I even doubt if there are any.

I suppose it would depend on the drug, the BP, the Lil’P. What are the data? In general, from my conversations and reading etc., BP’s are risk adverse and look for “larger” data bases before taking the plunge.

Phase two trials will up the numbers of patients treated to hundred(s), and if the data is as some here suspect, up the anti too.

sunstar